CAW
PFE icon

Cornerstone Advisors (Washington)’s Pfizer PFE Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$538K Buy
15,437
+1,152
+8% +$40.4K 0.06% 40
2020
Q2 		$443K Buy
14,285
+3,660
+34% +$124K 0.05% 48
2020
Q1 		$329K Buy
10,625
+60
+0.6% +$2.04K 0.05% 48
2019
Q4 		$393K Buy
10,565
+1,676
+19% +$59.7K 0.05% 49
2019
Q3 		$303K Sell
8,889
-131
-1% -$4.76K 0.04% 59
2019
Q2 		$371K Buy
9,020
+1,114
+14% +$44.2K 0.04% 76
2019
Q1 		$319K Buy
7,906
+2,617
+49% +$105K 0.03% 84
2018
Q4 		$219K Buy
5,289
+1,149
+28% +$47.7K 0.04% 107
2018
Q3 		$173K Buy
4,140
+723
+21% +$27.8K 0.11% 144
2018
Q2 		$118K Buy
3,417
+443
+15% +$15.1K 0.08% 177
2018
Q1 		$100K Sell
2,974
-844
-22% -$29K 0.07% 196
2017
Q4 		$131K Hold
3,818
– – 0.09% 159
2017
Q3 		$129K Hold
3,818
– – 0.09% 164
2017
Q2 		$122K Sell
3,818
-909
-19% -$28.7K 0.07% 161
2017
Q1 		$153K Sell
4,727
-77
-2% -$2.43K 0.08% 136
2016
Q4 		$148K Buy
4,804
+957
+25% +$29.2K 0.12% 124
2016
Q3 		$124K Buy
3,847
+570
+17% +$19.1K 0.1% 140
2016
Q2 		$109K Sell
3,277
-1,878
-36% -$59.9K 0.11% 103
2016
Q1 		$145K Buy
5,155
+80
+2% +$2.29K 0.15% 86
2015
Q4 		$155K Sell
5,075
-1,926
-28% -$60.6K 0.17% 81
2015
Q3 		$209K Buy
7,001
+677
+11% +$21.7K 0.18% 95
2015
Q2 		$201K Hold
6,324
– – 0.16% 100
2015
Q1 		$209K Buy
6,324
+52
+0.8% +$1.65K 0.16% 107
2014
Q4 		$185K Buy
6,272
+4,718
+304% +$135K 0.14% 117
2014
Q3 		$44K Sell
1,554
-111
-7% -$3.12K 0.04% 84
2014
Q2 		$47K Hold
1,665
– – 0.04% 92
2014
Q1 		$51K Buy
+1,665
New +$49.6K 0.06% 78

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cornerstone Advisors (Washington)'s PFE Position: Q3 2020 in Review

Cornerstone Advisors (Washington) increased its Pfizer (PFE) stake by 8.1% in Q3 2020, buying an estimated $40.4K and bringing the position to 15,437 shares worth $538K. The position accounts for 0.06% of the portfolio, ranked #40.

Cornerstone Advisors (Washington) first reported a position in PFE in Q1 2014 and has held it in 27 quarters since. 2,509 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

  • Cornerstone Advisors (Washington) held 15,437 shares of Pfizer worth $538K as of Q3 2020.
  • Cornerstone Advisors (Washington) bought 1,152 Pfizer shares in Q3 2020, an estimated $40.4K.
  • Pfizer made up 0.06% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #40 holding.
  • Cornerstone Advisors (Washington) first reported a position in Pfizer in Q1 2014 and has held it in 27 quarters since.
  • 2,509 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.